Page 43 - Abt News Today

Lee Danner & Bass Inc. boosted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 2.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,066 shares of the healthcare product maker’s stock after purchasing an additional 846 shares […]

Patten & Patten Inc. TN lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 184,731 shares of the healthcare product maker’s stock after selling 2,701 shares during the period. […]

Meitav Investment House Ltd. reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 11.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,000 shares of the healthcare product maker’s stock after selling 1,846 shares during the period. Meitav Investment House […]

Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 5.5% during the 3rd quarter, Holdings Channel.com reports. The firm owned 174,096 shares of the healthcare product maker’s stock after purchasing an additional 9,007 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s […]

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price objective lifted by research analysts at Royal Bank of Canada from $119.00 to $128.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the healthcare product maker’s stock. Royal Bank of Canada’s price objective points to a […]

Narwhal Capital Management lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 25.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 23,208 shares of the healthcare product maker’s stock after selling 8,115 shares during the period. Narwhal Capital Management’s […]

Parcion Private Wealth LLC reduced its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 37.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,041 shares of the healthcare product maker’s stock after selling 20,380 shares during the period. […]

Whittier Trust Co. increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.4% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 373,375 shares of the healthcare product maker’s stock after purchasing an additional 5,058 shares during the period. Whittier Trust Co.’s holdings […]

Abbott Laboratories (NYSE:ABT – Get Free Report) announced a quarterly dividend on Friday, December 15th, RTT News reports. Investors of record on Friday, January 12th will be given a dividend of 0.55 per share by the healthcare product maker on Thursday, February 15th. This represents a $2.20 annualized dividend and a yield of 1.95%. The […]

Capital Advisors Ltd. LLC lessened its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,887 shares of the healthcare product maker’s stock after selling 187 shares during the quarter. Capital Advisors Ltd. LLC’s holdings […]